398 related articles for article (PubMed ID: 7471084)
1. Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds.
Wood AW; Levin W; Chang RL; Huang MT; Ryan DE; Thomas PE; Lehr RE; Kumar S; Koreeda M; Akagi H; Ittah Y; Dansette P; Yagi H; Jerina DM; Conney AH
Cancer Res; 1980 Mar; 40(3):642-9. PubMed ID: 7471084
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
[TBL] [Abstract][Full Text] [Related]
3. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
Wood AW; Wislocki PG; Chang RL; Levin W; Lu AY; Yagi J; Hernandez O; Herina DM; Conney AH
Cancer Res; 1976 Sep; 36(9 pt.1):3358-66. PubMed ID: 788899
[TBL] [Abstract][Full Text] [Related]
4. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells.
Glatt H; Piée A; Pauly K; Steinbrecher T; Schrode R; Oesch F; Seidel A
Cancer Res; 1991 Mar; 51(6):1659-67. PubMed ID: 1900215
[TBL] [Abstract][Full Text] [Related]
5. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
Utesch D; Glatt H; Oesch F
Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of the enantiomers of the diastereomeric bay-region benz(a)anthracene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
Wood AW; Chang RL; Levin W; Yagi H; Thakker DR; van Bladeren PJ; Jerina DM; Conney AH
Cancer Res; 1983 Dec; 43(12 Pt 1):5821-5. PubMed ID: 6357432
[TBL] [Abstract][Full Text] [Related]
7. Sulfotransferase-mediated activation of 4-hydroxy- and 3,4-dihydroxy-3,4-dihydrocyclopenta[c,d]pyrene, major metabolites of cyclopenta[c,d]pyrene.
Surh YJ; Kwon H; Tannenbaum SR
Cancer Res; 1993 Mar; 53(5):1017-22. PubMed ID: 8439948
[TBL] [Abstract][Full Text] [Related]
8. Mutagenicity of the enantiomers of the diastereomeric bay-region benzo(c)phenanthrene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
Wood AW; Chang RL; Levin W; Thakker DR; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1984 Jun; 44(6):2320-4. PubMed ID: 6372992
[TBL] [Abstract][Full Text] [Related]
9. Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine.
Wood AW; Chang RL; Levin W; Kumar S; Shirai N; Jerina DM; Lehr RE; Conney AH
Cancer Res; 1986 Jun; 46(6):2760-6. PubMed ID: 3516386
[TBL] [Abstract][Full Text] [Related]
10. Arene imines, a new class of exceptionally potent mutagens in bacterial and mammalian cells.
Glatt H; Ludewig G; Platt KL; Waechter F; Yona I; Ben-Shoshan S; Jerushalmy P; Blum J; Oesch F
Cancer Res; 1985 Jun; 45(6):2600-7. PubMed ID: 3921247
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
[TBL] [Abstract][Full Text] [Related]
12. Mutagenicity and tumorigenicity of dihydrodiols, diol epoxides, and other derivatives of benzo(f)quinoline and benzo(h)quinoline.
Kumar S; Sikka HC; Dubey SK; Czech A; Geddie N; Wang CX; LaVoie EJ
Cancer Res; 1989 Jan; 49(1):20-4. PubMed ID: 2908847
[TBL] [Abstract][Full Text] [Related]
13. Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells.
Wislocki PG; Wood AW; Chang RL; Levin W; Yagi H; Hernandez O; Dansette PM; Herina DM; Conney AH
Cancer Res; 1976 Sep; 36(9 pt.1):3350-7. PubMed ID: 788898
[TBL] [Abstract][Full Text] [Related]
14. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
[TBL] [Abstract][Full Text] [Related]
15. Metabolic activation of cyclopenta(cd)pyrene to 3,4-epoxycyclopenta(cd)pyrene by rat liver microsomes.
Gold A; Eisenstadt E
Cancer Res; 1980 Nov; 40(11):3940-4. PubMed ID: 7008933
[TBL] [Abstract][Full Text] [Related]
16. Di-epoxides of the three isomeric dicyclopenta-fused pyrenes: ultimate mutagenic active agents.
Otero-Lobato MJ; Kaats-Richters VE; Havenith RW; Jenneskens LW; Seinen W
Mutat Res; 2004 Nov; 564(1):39-50. PubMed ID: 15474409
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of some dihydrodiols of several polycyclic aromatic hydrocarbons to mutagenic products by prostaglandin synthetase.
Guthrie J; Robertson IG; Zeiger E; Boyd JA; Eling TE
Cancer Res; 1982 May; 42(5):1620-3. PubMed ID: 6279279
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis and morphological transformation of mammalian cells by a non-bay-region polycyclic cyclopenta(cd)pyrene and its 3,4-oxide.
Gold A; Nesnow S; Moore M; Garland H; Curtis G; Howard B; Graham D; Eisenstadt E
Cancer Res; 1980 Dec; 40(12):4482-4. PubMed ID: 7438080
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the mutagenicity of compounds of known carcinogenicity, belonging to the benz[a]anthracene, chrysene, and cyclopenta[a]phenanthrene series, using Ames's test.
Coombs MM; Dixon C; Kissonerghis AM
Cancer Res; 1976 Dec; 36(12):4525-9. PubMed ID: 793712
[TBL] [Abstract][Full Text] [Related]
20. Mutagenicity of dihydrodiols and diol epoxides of dibenz[a, h]acridine in bacterial and mammalian cells.
Wood AW; Chang RL; Katz M; Conney AH; Jerina DM; Sikka HC; Levin W; Kumar S
Cancer Res; 1989 Dec; 49(24 Pt 1):6981-4. PubMed ID: 2684405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
